BioLife Solutions (BLFS) Tops Q3 EPS by 4c, Beats on Revenue; Offers FY24 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $38.61 --0%
Revenue Growth %: +3.9%
Financial Fact:
Cost of product sales: 920.94K
Today's EPS Names:
CFFI, ZGN, SSNC, More
Revenue Growth %: +3.9%
Financial Fact:
Cost of product sales: 920.94K
Today's EPS Names:
CFFI, ZGN, SSNC, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $30.57 million versus the consensus estimate of $25.54 million.
GUIDANCE:
BioLife Solutions sees FY2024 revenue of $98-100 million, versus the consensus of $110.6 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pharming Group N.V. (PHAR) Reports Q3 results; offers guidance
- Canaccord Downgrades NextDC (NXT:AU) to Spec. Buy
- Deutsche Bank Upgrades XP Power (XPP:LN) (XPPLF) to Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
